Biopharmaceutical R&D : the increased importance of cumulative innovation and related concerns -- The patent system as a system of balancing -- The patent system and some potential safety nets -- The right to health as an interpretive principle of patent law -- Unilateral conduct, IPRs and competition law : a systems' interaction -- The duty to deal under Art. 82 EC -- The duty to deal as applied to address technology access problems in the biopharmaceutical industry.
Series:
New horizons in competition law and economics series
This resource is supported by the Institute of Museum and Library Services under the provisions of the Library Services and Technology Act as administered by State Library of Iowa.